Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul R Parikh

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 12, 2021
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology GroupRahul R Parikh, Kara M Kelly, David C Hodgson, et al.
International Journal of Particle Therapy|September 30, 2024
ACR-ARS Practice Parameter for the Performance of Proton Beam TherapySteven J Frank, Indra J Das, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology GroupRichard W Tsang, Belinda A Campbell, Jayant S Goda, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 3, 2021
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief ReportJenna M Kahn, Joanna C Yang, Joachim Yahalom, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate CancerHaley K Perlow, Karishma Khullar, Ritesh Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2023
Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology GroupRaymond B Mailhot Vega, Paul D Harker-Murray, Christopher J Forlenza, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|November 12, 2021
Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology GroupRahul R Parikh, Kara M Kelly, David C Hodgson, et al.
International Journal of Particle Therapy|September 30, 2024
ACR-ARS Practice Parameter for the Performance of Proton Beam TherapySteven J Frank, Indra J Das, Charles B Simone, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology GroupRichard W Tsang, Belinda A Campbell, Jayant S Goda, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 3, 2021
Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief ReportJenna M Kahn, Joanna C Yang, Joachim Yahalom, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate CancerHaley K Perlow, Karishma Khullar, Ritesh Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2023
Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology GroupRaymond B Mailhot Vega, Paul D Harker-Murray, Christopher J Forlenza, et al.
The Lancet. Haematology|October 3, 2024
Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groupsOmran Saifi, Chelsea C Pinnix, Leslie K Ballas, et al.
Journal of the National Cancer Institute|April 11, 2026
Consensus radiation therapy organ at risk constraints for NCTN trials in hematologic malignanciesAustin J Sim, Bradford S Hoppe, Leslie K Ballas, et al.
Clinical Genitourinary Cancer|December 11, 2019
Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014Alexandra L Tabakin, Brian M Shinder, Sinae Kim, et al.
Prostate International|September 6, 2019
Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancerBertram E Yuh, Young Suk Kwon, Brian M Shinder, et al.
Pageof 7